Memorial Sloan Kettering Cancer Center
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Memorial Sloan Kettering Cancer Center sits in the top decile of US sponsors by registered trial count (#6 of 15,751 sponsors by registered trial count).
Memorial Sloan Kettering Cancer Center: 1,884 sponsored US clinical trials, 327 recruiting.
Memorial Sloan Kettering Cancer Center sponsors 1,884 registered US clinical trials on ClinicalTrials.gov, 327 of them currently recruiting, and 1,104 completed. 75 of these trials are in Phase 3-4 (later-stage) and 1,101 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Breast Cancer, with 98 trials.
Top-decile sponsor footprint
Memorial Sloan Kettering Cancer Center ranks in the top decile of sponsors by registered trial count (#6 of 15,751 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Open and recent trials
1,884 total, page 1 of 38
A Study of a New PET Scanner in People With Cancer
NCT07690917
A Study of ELI-002 7P, With or Without Tislelizumab, in People With Pancreatic Cancer
NCT07671339
A Study of CRD3874-SI in People With Leukemia
NCT07661095
A Study of a Urine Test to Detect Colorectal Cancer
NCT07649057
A Study of a Side Effects and Resource Navigation Program for People With Cancer
NCT07646847
FORTRAS: A Study of MSK-TCR5 in People With Solid Tumor Cancers
NCT07638371
A Study of Lower Dose Radiation Therapy for People With Prostate Cancer
NCT07635238
A Study of Cadonilimab Combined With Chemotherapy in People With Gastric or Gastroesophageal Junction Cancer
NCT07631000
A Study of Tepotinib and Ivonescimab in People With Non-Small Cell Lung Cancer
NCT07619339
A Study of Magnetic Resonance Imaging of the Pancreas for Cancer Screening
NCT07612046
A Study of Ivonescimab in People With Non-Small Cell Lung Cancer
NCT07594522
A Dietary Study for People With Clonal Hematopoiesis
NCT07590804
A Study of Meaning-Centered Therapy for Mexican Adults With Advanced Cancer
NCT07225309
Cord Blood Transplantation in Children and Young Adults With Blood Cancer
NCT07566377
A Study of Voice as a Way to Monitor for Side Effects in People Receiving CAR T-Cell Therapy
NCT07249528
Comparing Two Different Boost Approaches in Radiation Therapy for People With Prostate Cancer
NCT07548164
A Study of Cardiac Magnetic Resonance Imaging (CMR) for Evaluating Catheter-Associated Right Atrial Clot in People With Cancer
NCT07549477
A Study of Mirdametinib in People With Central Nervous System Tumors
NCT07539441
A Study of Ivonescimab, Chemotherapy, and Stereotactic Radiosurgery for People With Non-Small Cell Lung Cancer
NCT07535463
A Study of Ivonescimab in Combination With Dato-DXd or Osimertinib in People With Non-Small Cell Lung Cancer
NCT07535437
A Study of BMS-986504 With Standard-of-Care Therapy for People With Solid Tumor Cancer
NCT07532902
A Study of Ivonescimab in People With Leiomyosarcoma
NCT07516925
A Study of Methylprednisolone in People Having Liver Surgery
NCT07507643
A Study of the Impact of Endocrine Therapy on Surgical Outcomes in People With Breast Cancer
NCT07483307
A Study of Gefitinib, Trametinib, Disulfiram, and Sunitinib in Addition to Standard Chemotherapy in People With Osteosarcoma
NCT07477457
HERizon-Breast: A ctDNA-Guided Adaptive Study of Sequential Anti-HER2 Therapies and CNS Prophylaxis to Induce Long-Term Remission
NCT07459673
A Study Comparing Two Optical Coherence Tomography Devices in People With Ocular Tumors
NCT07449195
Study of a Support Program for Quality of Life in Chinese Cancer Patients and Survivors
NCT07454330
A Study of Elranatamab and Cyclophosphamide in People With Multiple Myeloma
NCT07454382
Registry Study of People Who Are Having an Esophagectomy and Are at High Risk of Anastomotic Leak
NCT07449208
A Study Testing Topical Pain-Relieving Herbal Plasters in People Who Are Using Opioids for Their Pain
NCT07447856
A Study of Trastuzumab Deruxtecan in People With Non-Small Cell Lung Cancer
NCT07428044
A Study of Obecabtagene Autoleucel in People With B-cell Acute Lymphoblastic Leukemia
NCT07400029
Using a Blood Test and Software Tool to Guide Treatment for Venous Thromboembolism
NCT07399977
A Study of the Combination of Ivosidenib, Azacitidine, and Venetoclax Followed by Ivosidenib Alone in People With Acute Myeloid Leukemia
NCT07392242
DESCANSO, a Mental Health Intervention for Depression, Insomnia, and Fatigue Symptoms in Latino People With Cancer
NCT07225088
A Study of Isoquercetin in People With Ovarian Cancer
NCT07303894
A Study of Neuropathy Caused by Enfortumab Vedotin in People With Urothelial Carcinoma
NCT07390617
A Study of Ruxolitinib for Preventing Graft-Versus-Host Disease in People With a Hematologic Malignancy Who Will Receive a Stem Cell Transplant
NCT07359859
A Study of Revumenib and Mezigdomide in People With Leukemia
NCT07356154
Registry for Bone Metastases
NCT07391410
A Study of BMS986365 in Combination With Degarelix in People With Prostate Cancer
NCT07335796
A Study of BIO 300 and Thoracic Radiation Therapy in People With Non-Small Cell Lung Cancer and Interstitial Lung Disease
NCT07323732
A Study of a Decision Tool for People Considering Breast Reconstruction Surgery
NCT07335354
Operator Radiation Exposure During Image-Guided Robotic-Assisted Bronchoscopy: A Multicenter Prospective Cohort Study
NCT07318402
Gabapentin And Breast Surgery Decision Architecture Randomization Trial (GABS-DART) Protocol
NCT07308717
A Study of Multiparametric Ultrasound Imaging (mpUS) for People With Endometrial Cancer
NCT07318415
Factors Associated With Breast Cancer Risks and Outcomes
NCT07294703
A Study of Pembrolizumab in People With Ultra-Rare Sarcomas
NCT07089992
ctDNA Testing to Inform Standard-of-Care Treatment Decisions in People With Endometrial Cancer
NCT07270666
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 461 |
| Phase 2 | 640 |
| Phase 3 | 67 |
| Phase 4 | 8 |
Therapeutic Areas
What is open in the Memorial Sloan Kettering Cancer Center pipeline
327 recruiting of 1,884 indexed (17% open); 1,104 completed (59%).
Phase mix: 75 late (III/IV) vs 1,101 early (I/II) (early-phase heavy).
Top condition: Breast Cancer (98 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page aggregates every registered trial from this sponsor, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.